1340 Transcutaneous Oxygen Monitoring, Hypoxic Range and Correlation With Prostaglandin E1

Pediatric Research - United States
doi 10.1203/00006450-198104001-01369
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Formation of Biologically Active 13,14-Dihydro-Prostaglandin E1 During Intravenous Infusion of Prostaglandin E1 in Newborns With Ductus Arteriosus-Dependent Congenital Heart Disease.

British Journal of Clinical Pharmacology
Pharmacology
1992English

Metabolism of Prostaglandin E1 in Dog Kidneys

British Journal of Pharmacology
Pharmacology
1970English

Recount of Prostaglandin E1 Therapy in a Patient With Raynaud's Phenomenon

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

EFFECTS OF PROSTAGLANDIN E1 ON tcPo2 AND tcPco2 IN PATIENTS WITH ARTERIOSCLEROSIS OBLITERANS

The journal of the Japanese Practical Surgeon Society
1989English

Transport of Prostaglandin E1 Across Rat Erythrocyte Membrane

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2008English

Prostaglandin E1 Therapy in Patients of Congenital Heart Disease With Pulmonary Atresia

The KITAKANTO Medical Journal
1994English

1331 Influence of Continuous Transcutaneous Oxygen Monitoring on the Incidence of Retinopathy of Prematurity (Rop)

Pediatric Research
Child HealthPediatricsPerinatology
1985English

Side Effects of Therapy With Prostaglandin E1 in Infants With Critical Congenital Heart Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

Inhibition of in Vivo Insulin Secretion by Prostaglandin E1

Journal of Clinical Investigation
Medicine
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy